The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Well said.
The company that keeps on giving.
Normally on AIM CEOs are terrible leaders who ramp their share prices up to keep their rubbish company in existence in order for them to keep their well paid noses in the trough. TC is a class act. PMG is a quality little company.
PS, there will also be added traction to the share price as those pesky shorts are closed. This will push the sp further north. Gla
Give it 12 months and this will see a 100-150% return, just as long as the business keeps on recovering. Plus points - no cash call, no further profit warnings, collections continue improving, CEO in the pipeline. The only way is up for the business now and the share price will follow.
Expecting more solid growth.
We're closer to it now than ever before my friend. Rome wasn't built in a day and these guys with all their outstanding contacts are going to build an Empire, give it 12-24 months, keep watching.
The business is solid and the company is heading in the right direction. I'm genuinely excited about the company's long term prospects, of all my holdings this is the one I feel will bring the largest long term rewards.
The subsidiary (forgot it's name off the top of my head) which is planning on opening up the internet signal spectrum is going to be huge, give it 24 months and ALM will be valued in the £Bs.
The new CEO is much more impressive than the last one, she has made the company more transparent which in turn has finally allowed me the make sense of what the company is upto. The wireless company is an absolute gem, I have no doubt it will eventually be worth multiples of ALMs current mrkt cap. Any further dips from here and I will top up.
This is great news. Anyone who plans on sticking around for a minimum of 1 year is going to be handsomely rewarded here. Hang on in there folks.
After all these recent small takeovers, that FLOW itself has now become a takeover target itself?
At 3p there was 0 success factored in. At 2p it's just ridiculous. If anything a commercial partner will now see this has more clarity now and less risky than previously. There is only upside from here IMO, a perfect opportunity to top if ever there was one.
But certainly not a terrible outcome. Technically only need a slight modification to have FDA approval. Next feedback just days away and plenty cash in the bank. This really is not that bad, in fact I bet the sp closes flat this afternoon.
I'm going for a Monday morning RNS with some more large buying on Friday afternoon.
You hit the nail on the head before Thelix re valuations. I have seen pharmas with big revenues and tiny profit have huge market caps. OXP to 10 bag from here within a year would be very realistic should everything go our way. What the company then does over the next 5 or so years, should there be more successful commercial drugs developed, then what's stopping OXP becoming a multibillion $ company in the long term. The next few weeks/months should not be the time frame to aim for IMO, more like 5-10 years for maximum (eye watering) returns.